Profile
Corporate information
Registration country
Registration country
Investment activity status
Active investor
Company type
Venture capital fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx.Overview
RMGP Biopharma Investment Fund is a Venture Capital (VC) Fund that invests in innovative, early stage biopharma assets, through its partnership with FutuRx. FutuRx is an Israel-based, globally focused drug development platform, founded by Orbimed, Johnson&Johnson and Takeda. RMGP's partnership with the incubator provides access to projects carefully selected by industry professionals, with potential to be first-in-class or best-in-class treatments for therapeutic areas with high unmet need (e.g.: oncology, rare diseases, autoimmune diseases, cardiovascular and metabolic diseases, neurodegenerative and other CNS disorders)
